Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2013-08-09 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-MARTIN-LEZ-TATINGHEM (62500), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE : revenue, balance sheet and financial ratios
SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-MARTIN-LEZ-TATINGHEM (62500),
this company of category PME
shows in 2024 a net income positive of 83 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE (SIREN 798091880)
Indicator
2024
2023
2022
2021
2020
2019
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
83 436 €
121 240 €
72 561 €
47 180 €
31 520 €
29 689 €
-4 631 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE generates positive net income of 83 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
83 436 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 83%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
20.311%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
82.913%
Solvency indicators evolution SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
Debt ratio
-484.792
1334.9
413.253
178.095
82.837
37.232
20.311
Financial autonomy
-4.004
6.959
19.452
35.9
54.614
72.779
82.913
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
20.312024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-25 pts over 3 years
In 2024, the debt ratio of SPFPL DE PHARMACIENS D'OF... (20.31) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
82.91%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+25 pts over 3 years
In 2024, the financial autonomy of SPFPL DE PHARMACIENS D'OF... (82.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 20442.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
20442.883
Liquidity indicators evolution SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2020
2021
2022
2023
2024
Liquidity ratio
0.099
7601.366
7080.597
10151.37
19004.222
35350.909
20442.883
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
20442.882024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of SPFPL DE PHARMACIENS D'OF... (20442.88) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE is estimated at
1 164 828 €
(range 811 167€ - 1 742 649€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
811k€1164k€1742k€
1 164 828 €Range: 811 167€ - 1 742 649€
NAF 5 année 2024
Valuation method used
Net Income Multiple
83 436 €
×
14.0x
=1 164 828 €
Range: 811 168€ - 1 742 650€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE with other companies in the same sector:
Frequently asked questions about SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE
What is the revenue of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE ?
The revenue of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE is not publicly disclosed (confidential accounts filed with INPI).
Is SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE profitable?
Yes, SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE generated a net profit of 83 k€ in 2024.
Where is the headquarters of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE ?
The headquarters of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE is located in SAINT-MARTIN-LEZ-TATINGHEM (62500), in the department Pas-de-Calais.
Where to find the tax return of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE ?
The tax return of SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE operate?
SPFPL DE PHARMACIENS D'OFFICINE LENGAGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart